APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

简称 APPL IMMUNOHISTO M M ·UNITED STATES ·出版周期 Bimonthly ·年均收录 83 篇

1.2

最新影响因子

100.00%

自引率

较易

投稿难度

较慢,6-12周

审稿周期

期刊简介

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY是一本专注于免疫组织化学和分子形态学研究的学术期刊，ISSN号为1541-2016，由美国出版商Lippincott Williams & Wilkins出版，出版地为美国，出版周期为双月刊。该期刊的影响因子根据年份有所不同，最新数据需查询JCR报告，目前未被列为开放获取（OA）期刊，但被SCI收录，中科院分区情况需根据最新分区表确认。该杂志的发文特点集中于免疫组织化学技术、分子形态学及其在病理学和临床诊断中的应用，研究领域涵盖肿瘤标志物、组织病理学、分子诊断等。杂志质量较高，审稿严格，适合相关领域的研究者投稿，但需注意其影响因子波动可能带来的投稿风险，同时非OA性质可能导致读者获取成本较高。

影响因子趋势

近期发表

Neuroendocrine Differentiation in Synovial Sarcoma—An Immunohistochemical Study of 357 Tumors With 4 Markers: Chromogranin A, Synaptophysin, Insulinoma-associated Protein 1 and Insulin Gene Enhancer Protein ISL-1 2026-09-10

Profiling NFκB and VEGF Expression in Mouse Embryonic Stem Cells, Lung Cancer Cells, and Fibroblasts 2026-09-02

ISIMM Page 2026-09-03

PRAME Expression in Merkel Cell Carcinoma: Correlation With MCPyV Status, PD-L1, and Tumor-Infiltrating Lymphocytes in a Multicenter Cohort 2026-08-25

Immunohistochemistry Assay Based on Ready-To-Use Antibodies and Vendor-Recommended Protocol Settings Often Perform Suboptimally 2026-08-21

A Single-Center Comparative Study of the c-MET Immunohistochemistry SP44 and LBP4 Assays in Chinese Non-Small Cell Lung Cancer (NSCLC) Cohort 2026-08-18

Inter-Rater Agreement in PD-L1 (22C3) Expression Evaluation in Colon Cancer 2026-08-17

Differential Immunohistochemical Expression of GATA6 and GATA3 in Esophageal Carcinoma: Correlation With Clinicopathologic Parameters and Patients’ Survival 2026-07-02

Immunohistochemical Expression of RhoJ Protein in Breast Carcinoma 2026-08-05

Prognostic Biomarkers in Ductal Carcinoma in Situ: An Interobserver Agreement Study 2026-08-03